Parkinsonism Associated with Anti‐B‐Cell Maturation Antigen Chimeric Antigen Receptor T‐Cell Therapy
Movement Disorders Clinical Practice · 2024-12 · 11 (12) · 1625-1628
DOI: 10.1002/mdc3.14239 ↗Kurz gefasst
Fallbericht in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 21.10.2024. Verfasst von Sabine Schneider und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Sabine Schneider, Whitley W Aamodt
Zitieren
APA
Schneider, S., Aamodt, W. W., Pruitt, A. A., & Berger, J. R. (2024). Parkinsonism Associated with Anti‐B‐Cell Maturation Antigen Chimeric Antigen Receptor T‐Cell Therapy. Movement Disorders Clinical Practice, 11(12), 1625-1628. https://doi.org/10.1002/mdc3.14239
Vancouver
Schneider S, Aamodt WW, Pruitt AA, Berger JR. Parkinsonism Associated with Anti‐B‐Cell Maturation Antigen Chimeric Antigen Receptor T‐Cell Therapy. Movement Disorders Clinical Practice. 2024;11(12):1625-1628. doi:10.1002/mdc3.14239
BibTeX
@article{Schneider2024,
author = {Schneider, Sabine and Aamodt, Whitley W and Pruitt, Amy A and Berger, Joseph R},
title = {Parkinsonism Associated with Anti‐B‐Cell Maturation Antigen Chimeric Antigen Receptor T‐Cell Therapy},
journal = {Movement Disorders Clinical Practice},
year = {2024},
volume = {11},
number = {12},
pages = {1625--1628},
doi = {10.1002/mdc3.14239}
}
EUVIMED